Webinar: Onco-Hu® Mice for Evaluation of Immuno-Oncology Therapeutics

Join this webinar to learn about cutting edge preclinical mouse platforms used to evaluate immuno-modulatory therapies for human cancer. Discussion topics include:

  • Overview of Onco-Hu® mice (tumor bearing hu-NSG™ and hu-NSG™-SGM3)
  • Growth kinetics of patient derived tumors (PDX) in NSG™ vs. hu-NSG™
  • Comparison of human immune reconstitution in NSG™ vs. NSG™-SGM3 mice
  • Therapeutic response to chemotherapy and an anti-PD1 check-point inhibitor in Onco-Hu® mice

watch now

Registration is Open